Mylan’s Cancellation of Apriso Patent Affirmed by Fed. Cir. Bloomberg Law
Mylan Pharmaceuticals Inc.’s win in a suit that invalidated a patent related to the ulcerative colitis drug Apriso was upheld by the Federal Circuit June 12.
Mylan’s Cancellation of Apriso Patent Affirmed by Fed. Cir. Bloomberg Law
Mylan Pharmaceuticals Inc.’s win in a suit that invalidated a patent related to the ulcerative colitis drug Apriso was upheld by the Federal Circuit June 12.